The results of the study demonstrate increased levels of gum disease, and disease-causing bacteria, in individuals at risk of rheumatoid arthritis (RA).
Drugs used to treat rheumatoid arthritis may impact mental health by improving pain and stiffness and by targeting inflammatory processes common to arthritis and depression; however, a recent review demonstrates that relying on rheumatoid arthritis therapies alone may not meaningfully improve patients’ mental health.
A new study has revealed that pregnant women with rheumatoid arthritis (RA) may be able to use certain RA drugs without possible increased health risks to their unborn babies.
Scientists have understood little about how chikungunya and related viruses cause arthritis. Now, researchers at have identified the molecular handle that chikungunya grabs to get inside cells. The findings could lead to ways to prevent or treat disease caused by chikungunya and related viruses.
Using new analytic tools, researchers have decoded the epigenetic landscape for rheumatoid arthritis (RA), a common autoimmune disease that affects more than 1.3 million Americans.
For patients with chronic conditions like arthritis or diabetes, arguments with a spouse may have physical repercussions, according to researchers. They found that in two groups of older individuals — one group with arthritis and one with diabetes — the patients who felt more tension with their spouse also reported worse symptoms on those days.
A novel PET tracer can visualize joint inflammation and could provide early diagnosis of rheumatoid arthritis, a common autoimmune disease that causes chronic inflammation of joints and can lead to deformity and dysfunction.
Unintentional weight loss also linked with worsening disability, perhaps related to frailty.
Bioengineers and physicians team up to develop a better delivery system for getting anti-inflammatory therapies to the sites where they are needed most.
Scientists are bringing precision medicine to rheumatoid arthritis for the first time by using genetic profiling of joint tissue to see which drugs will work for which patients, reports a new multi-site study. In the near future, patients won’t have to waste time and be disappointed with months of ineffective therapy, scientists said. Currently $2.5 billion a year is wasted on therapy that doesn’t work.